Answer

Management commentary on XiR mix and international placements (Intuitive Surgical, Q2 2026)

What management said about XiR mix (how much of placements/customers it represents)

Management said XiR is expected to be a “significant part of our placements over the coming quarters”. ¹
In the U.S. ASC channel specifically, management noted 27 system placements at ASCs in Q2, and 20 of those 27 were XiR systems—i.e., ~74% of ASC placements were XiR that quarter. ²
Management characterized XiR as a cost-sensitive option that benefits from the breadth of the Gen 4 ecosystem, and said they expect it to meet customer economic needs in segmented markets. ³¹
They also described longer-run upgrade-cycle dynamics: while they do not have a “perfect prediction,” management referenced history (da Vinci Si to Xi taking “about 7 years” to reach peak trade volume) and said upgrade cycles occur over multiple years. ⁴

What management said about XiR international placements (where it’s going, and why)

Management said XiR provides access to customers not yet invested in robotics, allowing them to start with XiR, learn, see benefits, and potentially become customers for more advanced technology over time. ³
They provided field/customer footprint for XiR:
- Installed base of “something like a 130 XiRs in the field,” with about 50 in the U.S. ³
- They said a large portion are in international markets, and that ~11 or 12 customers in ~11 or 12 countries took an XiR over the roughly one-year period since they had XiR “for about a year now.” ³
They connected international adoption to market segmentation and economics: management said they see diverse interest in cost-sensitive places and highlighted that XiR is “advantaged by the breadth of the Gen 4 ecosystem.” ³
Management explicitly tied international system placement patterns to XiR growth:
- In Q2, they said da Vinci adoption of and increased adoption of XiR is particularly in “more cost constrained countries outside the US” and in “ambulatory surgery centers in the US.” ⁵
On specific regions outside the U.S., they gave context on system placement totals and geography, which frames the environment in which XiR is being adopted:
- Outside the U.S., they placed 201 systems (+12% year over year), including 75 in Asia, 79 in Europe, and 47 in Rest of world. ²
- They also noted Japan-specific strength dynamics (though not exclusively XiR) where they discussed government/reimbursement effects: management said Japan was impacted by government funding and that reimbursement decisions effective in June are “positive,” with cautious optimism. ⁶
- For distributor markets broadly, they said they continued to see relative strength and that 42 of the 71 placements were X or XiR systems in those markets during the quarter. ⁷

Bottom-line takeaway from management’s remarks

XiR mix: Management’s guidance was qualitative but clear—XiR is positioned as a material (potentially “significant”) component of upcoming placements, with especially strong representation in U.S. ASC placements (20 of 27 in Q2). ¹²
International placements: XiR adoption is being described as internationally meaningful (large portion of the ~130 XiR installed base, with international uptake across ~11–12 countries in about a year) and management attributes that to access for robotics-naïve customers and fit with cost-constrained healthcare systems, supported by the Gen 4 ecosystem. ³⁵

References

Intuitive Surgical, Inc. (ISRG) earnings transcript 2026 - Q2

Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.

Intuitive Surgical Highlights XiR Mix as Significant Driver in Q2 2026 Placements

Sources used

Research question

Answer

Management commentary on XiR mix and international placements (Intuitive Surgical, Q2 2026)

What management said about XiR mix (how much of placements/customers it represents)

What management said about XiR international placements (where it’s going, and why)

Bottom-line takeaway from management’s remarks

References

Keep Reading

Intuitive Surgical notes private-pay majority with modest ACA impact on utilization in Q2 2026

Keep Reading

Keep Reading

Intuitive Surgical notes private-pay majority with modest ACA impact on utilization in Q2 2026

Intuitive Surgical Q2 2026 Upgrades XiR Access and Capex Underpinnings Drive Procedure Growth

Intuitive Surgical's 2026 International Growth Strategy Unveiled

Intuitive Surgical 2026 AI & Digital Innovation Budget Strategy

Medtronic Highlights Affera Center Utilization Expansion in Q1 2027

Keurig Dr Pepper Nears Double-Digit Energy Share in Q2 2026

Vistra's 2026 Market Growth: Demand Signals and Backlog Insights

Exelon's 2026 Supply Shortages Outlook and Market Trends

Impact of Middle East Conflict on Emerson's Q2 2026 Sales Growth and Market Dynamics

Lincoln Electric Q1 2026 Demand Outlook: Americas Lead Recovery

VICI Properties' 2026 Guidance and Market Outlook on Experiential Real Estate

U.S. LNG and NGL Export Outlook for 2026: Market Expectations and Constraints